Cannon Gillian (CIK 1833910) reported 5 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-08). Recent activity: Sell XENE (1,190 shares), Buy XENE (2,645 shares), Sell CORT (7,393 shares), Buy CORT (11,000 shares), Sell CORT (3,607 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-08 | Xenon Pharmaceuticals Inc. (XENE) | Director | Sell | 1,190 | $63,237 |
| 2026-06-03 | Xenon Pharmaceuticals Inc. (XENE) | Director | Buy | 2,645 | $0 |
| 2025-09-11 | CORCEPT THERAPEUTICS INC (CORT) | Director | Sell | 7,393 | $0 |
| 2025-09-08 | CORCEPT THERAPEUTICS INC (CORT) | Director | Buy | 11,000 | $252,890 |
| 2025-09-08 | CORCEPT THERAPEUTICS INC (CORT) | Director | Sell | 3,607 | $252,959 |
Source: SEC Form 4 filings · as of 2026-06-08